<scp>HER</scp>2 challenge contest: a detailed assessment of automated <scp>HER</scp>2 scoring algorithms in whole slide images of breast cancer tissues
AIMS: Evaluating expression of the human epidermal growth factor receptor 2 (HER2) by visual examination of immunohistochemistry (IHC) on invasive breast cancer (BCa) is a key part of the diagnostic assessment of BCa due to its recognized importance as a predictive and prognostic marker in clinical practice. However, visual scoring of HER2 is subjective, and consequently prone to interobserver variability. Given the prognostic and therapeutic implications of HER2 scoring, a more objective method
OpenAlex
3284d ago
Healthcare